• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ara-5-氮杂胞苷三磷酸(ara-5-aza-CTP)和阿糖胞苷三磷酸(ara-CTP)对体外纯化的人DNA聚合酶DNA合成的序列特异性影响:在特定模板上链延伸的可视化

Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.

作者信息

Townsend A J, Cheng Y C

机构信息

Pharmacology Department, University of North Carolina, Chapel Hill 27514.

出版信息

Mol Pharmacol. 1987 Sep;32(3):330-9.

PMID:2444869
Abstract

1-beta-D-arabinofuranosyl-5-aza-cytosine (ara-5-aza-Cyd) is an analog of 1-beta-D-arabinofuranosylcytosine (ara-C), which resembles ara-C in anabolic metabolism, incorporation into DNA, and inhibition of DNA replication. Human T-lymphoblastic cells (Molt-4) incorporate three- to fivefold more ara-5-aza-Cyd than ara-C into DNA during 5-8 hr exposure. Although ara-5-aza-Cyd and its triphosphate metabolite are unstable in aqueous solution, the aza-analog was much more stable in solution when incorporated into native DNA isolated from Molt-4 cells. By using gapped duplex DNA as a substrate for purified human DNA polymerases alpha and beta, inhibition of [3H]-dCTP incorporation by ara-5-aza-CTP and ara-CTP was competitive, with Ki values for alpha of 11 and 1.5 microM, respectively. Ki values for polymerase beta were 39 and 7.6 microM, respectively. A DNA elongation assay was adapted from DNA sequencing technology, using singly primed bacteriophage M13mp19 or M13mp9 (+)-DNA. Elongation of 5'-[32P]-labeled primer by polymerase alpha is slowed considerably by incorporation of one ara-CMP and to a lesser extent after incorporation of one ara-5-aza-CMP. Neither analog significantly affected elongation by polymerase beta after a single incorporation. However, neither polymerase alone could appreciably extend the growing chain if two consecutive ara-5-aza-CMP or ara-CMP analogs were incorporated. Thus, if similar mechanisms are operant in intact cells, the greater incorporation of ara-5-aza-Cyd than ara-C into DNA may be due to a more facile elongation of the nascent DNA strand by polymerase alpha after incorporation of a single analog. The effect in vitro of incorporation of either analog on DNA chain elongation is widely variable, depending on the identity of the polymerase involved and the sequence of the DNA template being copied.

摘要

1-β-D-阿拉伯呋喃糖基-5-氮杂胞嘧啶(ara-5-氮杂胞苷)是1-β-D-阿拉伯呋喃糖基胞嘧啶(ara-C)的类似物,在合成代谢、掺入DNA以及抑制DNA复制方面与ara-C相似。人T淋巴细胞母细胞(Molt-4)在暴露5-8小时期间,掺入DNA中的ara-5-氮杂胞苷比ara-C多三至五倍。尽管ara-5-氮杂胞苷及其三磷酸代谢产物在水溶液中不稳定,但当掺入从Molt-4细胞分离的天然DNA中时,这种氮杂类似物在溶液中更稳定。通过使用缺口双链DNA作为纯化的人DNA聚合酶α和β的底物,ara-5-氮杂胞苷三磷酸(ara-5-aza-CTP)和ara-胞苷三磷酸(ara-CTP)对[3H]-dCTP掺入的抑制是竞争性的,α的Ki值分别为11和1.5微摩尔。聚合酶β的Ki值分别为39和7.6微摩尔。DNA延伸测定法是根据DNA测序技术改编的,使用单引物噬菌体M13mp19或M13mp9(+)-DNA。聚合酶α对5'-[32P]-标记引物的延伸在掺入一个ara-CMP后显著减慢,在掺入一个ara-5-氮杂胞苷一磷酸(ara-5-aza-CMP)后减慢程度较小。单次掺入后,这两种类似物对聚合酶β的延伸均无显著影响。然而,如果掺入两个连续的ara-5-aza-CMP或ara-CMP类似物,单独的两种聚合酶都不能明显延长生长链。因此,如果完整细胞中存在类似机制,ara-5-氮杂胞苷比ara-C更多地掺入DNA可能是由于在掺入单个类似物后,聚合酶α对新生DNA链的延伸更容易。两种类似物掺入对DNA链延伸的体外影响差异很大,这取决于所涉及的聚合酶的特性以及被复制的DNA模板的序列。

相似文献

1
Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.ara-5-氮杂胞苷三磷酸(ara-5-aza-CTP)和阿糖胞苷三磷酸(ara-CTP)对体外纯化的人DNA聚合酶DNA合成的序列特异性影响:在特定模板上链延伸的可视化
Mol Pharmacol. 1987 Sep;32(3):330-9.
2
Incorporation of fludarabine and 1-beta-D-arabinofuranosylcytosine 5'-triphosphates by DNA polymerase alpha: affinity, interaction, and consequences.DNA聚合酶α对氟达拉滨和1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸的掺入:亲和力、相互作用及后果。
Clin Cancer Res. 1997 Aug;3(8):1347-55.
3
Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).1-β-D-阿拉伯呋喃糖基-5-氮杂胞嘧啶的代谢及其掺入人T淋巴细胞白血病细胞(Molt-4)的DNA中。
Cancer Res. 1985 Aug;45(8):3522-8.
4
Effects of 1-beta-D-arabinofuranosylcytosine incorporation on elongation of specific DNA sequences by DNA polymerase beta.1-β-D-阿拉伯呋喃糖基胞嘧啶掺入对DNA聚合酶β催化特定DNA序列延伸的影响。
Cancer Res. 1988 Mar 15;48(6):1494-8.
5
Incorporation of 5-Aza-2'-deoxycytidine-5'-triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase.5-氮杂-2'-脱氧胞苷-5'-三磷酸掺入DNA。与哺乳动物DNA聚合酶α和DNA甲基化酶的相互作用。
Mol Pharmacol. 1983 Jul;24(1):109-14.
6
Altered sensitivity to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate of DNA polymerase alpha from leukemic blasts of acute lymphoblastic leukemia.急性淋巴细胞白血病白血病原始细胞中DNA聚合酶α对1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸的敏感性改变。
Cancer Res. 1982 Feb;42(2):649-53.
7
1-beta-D-arabinofuranosylcytosine nucleotide inhibition of sialic acid metabolism in WI-38 cells.1-β-D-阿拉伯呋喃糖基胞嘧啶核苷酸对WI-38细胞中唾液酸代谢的抑制作用
Cancer Res. 1980 Jun;40(6):1940-3.
8
Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.去磷酸化在人淋巴细胞系中1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸积累中的作用及其与药物敏感性的关系
Cancer Res. 1982 Jul;42(7):2846-51.
9
1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.1-β-D-阿拉伯呋喃糖基胞嘧啶的代谢及其掺入DNA作为体内小鼠肿瘤细胞反应的决定因素。
Cancer Res. 1985 Dec;45(12 Pt 1):6244-9.
10
Inhibition of DNA primase by nucleoside triphosphates and their arabinofuranosyl analogs.核苷三磷酸及其阿拉伯呋喃糖基类似物对DNA引发酶的抑制作用。
Mol Pharmacol. 1987 Feb;31(2):146-51.

引用本文的文献

1
Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers.白血病和淋巴瘤中阿糖胞苷治疗的反应与毒性:从剂量难题到药物基因组生物标志物
Cancers (Basel). 2021 Feb 25;13(5):966. doi: 10.3390/cancers13050966.
2
Sensitive CometChip assay for screening potentially carcinogenic DNA adducts by trapping DNA repair intermediates.通过捕获 DNA 修复中间体筛选潜在致癌性 DNA 加合物的敏感彗星芯片分析。
Nucleic Acids Res. 2020 Feb 20;48(3):e13. doi: 10.1093/nar/gkz1077.
3
Pharmacodynamics of cytarabine induced leucopenia: a retrospective cohort study.
阿糖胞苷诱导白细胞减少的药效学:一项回顾性队列研究。
Br J Clin Pharmacol. 2015 Apr;79(4):685-91. doi: 10.1111/bcp.12530.
4
Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer.用于癌症治疗的嘌呤和嘧啶抗代谢物的酶学
Chem Rev. 2009 Jul;109(7):2880-93. doi: 10.1021/cr900028p.
5
Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia.1-β-D-阿拉伯呋喃糖基胞嘧啶5'-三磷酸(一种细胞内活性代谢物)与N(4)-山嵛酰基-1-β-D-阿拉伯呋喃糖基胞嘧啶治疗急性髓性白血病的疗效密切相关。
Jpn J Cancer Res. 2001 Sep;92(9):975-82. doi: 10.1111/j.1349-7006.2001.tb01188.x.
6
ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.ATR介导的检查点通路调节人类Chk1的磷酸化和激活。
Mol Cell Biol. 2001 Jul;21(13):4129-39. doi: 10.1128/MCB.21.13.4129-4139.2001.
7
Biological effects of a relatively low concentration of 1-beta-D-arabinofuranosylcytosine in K562 cells: alterations of the cell cycle, erythroid-differentiation, and apoptosis.低浓度1-β-D-阿拉伯呋喃糖基胞嘧啶对K562细胞的生物学效应:细胞周期、红系分化及凋亡的改变
Mol Cell Biochem. 1998 Oct;187(1-2):211-20. doi: 10.1023/a:1006874931249.
8
New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase.用于实体瘤治疗的嘧啶抗代谢物新靶点。2:脱氧胞苷激酶。
Pharm World Sci. 1994 Apr 15;16(2):104-12. doi: 10.1007/BF01880661.
9
Evolution of the arabinosides and the pharmacology of fludarabine.阿拉伯糖苷的演变与氟达拉滨的药理学
Drugs. 1994;47 Suppl 6:30-8. doi: 10.2165/00003495-199400476-00006.
10
Cerebrospinal fluid pharmacokinetics and toxicology of intraventricular and intrathecal arabinosyl-5-azacytosine (fazarabine, NSC 281272) in the nonhuman primate.非人灵长类动物脑室内和鞘内注射阿拉伯糖基-5-氮杂胞苷(法扎拉滨,NSC 281272)的脑脊液药代动力学和毒理学
Invest New Drugs. 1993 May-Aug;11(2-3):135-40. doi: 10.1007/BF00874147.